Flu and Whooping Cough Vaccines Don’t Harm Babies: Study

Infants whose moms received the shots when they were pregnant were no more at risk of dying or being hospitalized than other babies.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, JOVANMANDICFrom a study of more than 400,000 babies, researchers report in Pediatrics this week (February 20) that influenza and whooping cough vaccines are safe during pregnancy. The children of moms who received the immunizations while expecting had no higher risk of hospitalization or death in the first six months of life than kids of other moms.

“The fact that the authors found no reason to believe exposure to vaccines during pregnancy caused serious harm to infants in the first six months of life is reassuring,” Annette Regan, a public health researcher at Curtin University in Australia, tells Reuters by email. “While other studies have looked at hospital admissions, this is the first study to evaluate the impact on mortality.”

Public health officials already recommend that pregnant women receive the flu and so-called Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccines. For this study, the researchers examined 413,000 babies’ medical records collected from a number of healthcare systems. While more than 25,000 babies ended up going to the hospital before six months of age and 157 babies died, the authors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies